Last reviewed · How we verify
Inactive Clear Patch
An inactive clear patch formulation designed as a control or placebo delivery system for transdermal applications.
At a glance
| Generic name | Inactive Clear Patch |
|---|---|
| Also known as | Placebo transdermal patch |
| Sponsor | University of North Carolina, Chapel Hill |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This product appears to be a pharmaceutical delivery device or control formulation rather than an active therapeutic agent. As a marketed product from UNC Chapel Hill, it likely serves as a reference standard, educational tool, or inert comparator in transdermal patch research and development.
Approved indications
Common side effects
Key clinical trials
- Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach (PHASE4)
- Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |